SAVA
Companies
NASDAQ
Cassava Sciences Inc.
Health Care
$2.07
-$0.29 (-12.29%)
Price Chart
Overview
About SAVA
refer to descriptions included in the company's filings with the securities and exchange commission for more information about the company. the company does not intend to update and does not take responsibility for any information published on linkedin.
Market Cap
$941.8M
Volume
3.6M
Avg. Volume
4.4M
P/E Ratio
-0.67231643
Dividend Yield
0.00%
Employees
29.0
Company Information
Latest News for SAVA
Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop
March 25, 2025
6 Favorite Biotech Bets For 2023
January 9, 2023
US opens criminal probe into pharma company over potential Alzheimer's drug fraud: report
July 27, 2022
Cassava Sciences stock pops after rival experiences setback in Alzheimer's research
November 14, 2022
Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround
April 1, 2025
Risk & Correlation Analysis
Market Correlation
1.43
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SAVA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025